Related references
Note: Only part of the references are listed.Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors
Ruth Percik et al.
AUTOIMMUNITY REVIEWS (2020)
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study
Norio Okada et al.
BRITISH JOURNAL OF CANCER (2020)
Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor-induced secondary adrenal insufficiency
Seiichi Yano et al.
EUROPEAN JOURNAL OF CANCER (2020)
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study
Tomoko Kobayashi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society
Hiroshi Takagi et al.
ENDOCRINE JOURNAL (2020)
Comparative analysis of human leucocyte antigen between idiopathic and anti-PD-1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study
Hidefumi Inaba et al.
CLINICAL ENDOCRINOLOGY (2019)
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis
Alexander Faje et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases
Isabella Lupi et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2019)
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society
Hiroshi Arima et al.
ENDOCRINE JOURNAL (2019)
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
Alexander T. Faje et al.
CANCER (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
Shiro Kimbara et al.
CANCER SCIENCE (2018)
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study
Tomoko Kobayashi et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis
Naoko Iwata et al.
PITUITARY (2017)
Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade Insights into Pathogenesis from an Autopsy Series
Patrizio Caturegli et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline
Toshihiko Yanase et al.
ENDOCRINE JOURNAL (2016)
Nivolumab: A Review in Advanced Melanoma
Lesley J. Scott
DRUGS (2015)
Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis
Shintaro Iwama et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis
Anthony P. Heaney et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Detection of Pituitary Antibodies by Immunofluorescence: Approach and Results in Patients With Pituitary Diseases
Adriana Ricciuti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody
Shintaro Iwama et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Isolated Prolactin Deficiency Associated With Serum Autoantibodies Against Prolactin-Secreting Cells
Shintaro Iwama et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis
M. A. Landek-Salgado et al.
PITUITARY (2012)
Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer
Grazia Graziani et al.
PHARMACOLOGICAL RESEARCH (2012)
Lymphocytic hypophysitis:: Report of two biopsy proven cases and one suspected case with pituitary autoantibodies
S. Bensing et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
